1 Introduction
Borderline personality disorder (BPD) is characterized by emotional instability, tumultuous interpersonal relationships, marked impulsivity, intense fear of abandonment, and self-destructive behaviors (1). These symptoms can significantly disrupt daily functioning and diminish quality of life (2). Individuals living with BPD often struggle to maintain consistent relationships (3), manage daily responsibilities and regulate their emotions effectively (4, 5). These challenges can lead to considerable difficulties in various aspects of life, including their personal, social, and professional spheres, ultimately reducing their overall sense of fulfillment and well-being (6). Additionally, individuals with BPD are at increased risk for premature death, primarily due to elevated suicide rates and high burden of physical health complications (7, 8). BPD is estimated to affect approximately 1.9% of the general population (9) but accounts for 15–28% of patients in psychiatric settings, including clinics and hospitals, as well as a significant number of individuals seeking psychological support in general healthcare facilities (10).
1.1 Challenges in accessing and retaining effective treatment for BPD
Clinical guidelines generally recommend psychotherapy as the first-line treatment for BPD, with Dialectical Behavior Therapy (DBT) often highlighted, despite no consensus regarding the superiority of any psychological intervention (11). However, access to adequate treatment for BPD remains limited in most countries because of significant shortage of qualified professionals, insufficient funding and ongoing stigmatization of this population within the healthcare system (12–14). As a result, many individuals are left without access to the recommended care, as the demand for these services far exceeds the available supply (13). Individuals with BPD frequently report dissatisfaction with the services they receive, citing a significant disparity between their needs and the care provided, while also facing critical stigmatization (15). Although DBT and other psychotherapies are recognized as the most effective treatments, meta-analyses have shown only moderate effect sizes in reducing BPD symptoms with psychotherapy (16). Additionally, a meta-analysis indicates that the dropout rate for outpatient psychotherapies is 28.2% (17), highlighting the challenges of retaining patients in these therapeutic programs.